Edition:
India

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

7.00USD
23 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.00
Open
$7.00
Day's High
$7.14
Day's Low
$6.99
Volume
121,997
Avg. Vol
345,379
52-wk High
$8.63
52-wk Low
$4.61

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.20 December 24 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.25 1.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 4 6.03 7.70 4.30 --
Quarter Ending Sep-18 4 13.72 29.10 5.80 --
Year Ending Dec-18 5 38.59 76.90 21.50 97.67
Year Ending Dec-19 4 87.93 94.60 73.40 129.88
Earnings (per share)
Quarter Ending Jun-18 3 -0.20 -0.16 -0.24 --
Quarter Ending Sep-18 3 -0.09 0.09 -0.24 --
Year Ending Dec-18 5 -0.61 -0.10 -0.83 0.06
Year Ending Dec-19 3 -0.09 0.06 -0.30 0.43

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 3.20 3.89 0.69 21.53
Quarter Ending Sep-17 3.52 2.70 0.82 23.38
Quarter Ending Jun-17 3.67 2.77 0.91 24.76
Quarter Ending Mar-17 4.49 2.35 2.15 47.75
Quarter Ending Dec-16 4.44 4.65 0.21 4.75

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6.03 6.03 6.65 9.30 --
Quarter Ending Sep-18 13.72 13.72 13.72 11.70 --
Year Ending Dec-18 38.59 38.59 42.54 41.52 97.67
Year Ending Dec-19 87.93 87.93 87.93 88.87 129.88

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 1
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 2
Year Ending Dec-19 0 0 0 0
Earnings